Revance Therapeutics, Inc. SC 13D and SC 13D/A reports

Location
1222 Demonbreun Street, Suite 2000, Nashville, Tennessee
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
5/10/2024, 04:16 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Oct 24, 2023
SC 13D Report SC 13D Sep 1, 2023